ADMA BIOLOGICS, INC. Gain (Loss) on Non-Recourse Debt
ADMA BIOLOGICS, INC. (ADMA) reported Gain (Loss) on Non-Recourse Debt of -$719.10 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-11.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnNonRecourseDebt · last filed 2015-08-11
- 2015-06-30: Gain (Loss) on Non-Recourse Debt 6 month -$719.10K.
- 2014-06-30: Gain (Loss) on Non-Recourse Debt 6 month $0.00.
| Period end | Gain (Loss) on Non-Recourse Debt 6 month |
|---|---|
| 2015-06-30 | -$719.10K 10-Q · filed 2015-08-11 |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |